The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and Human Services, at which HHS Secretary Alex Azar testified. Released yesterday, the non-binding budget request proposes hundreds of billions of dollars in reductions to Medicare and Medicaid over 10 years. It also contains a number of provisions related to drug pricing, opioids and other health-related issues. In a statement yesterday, AHA President and CEO Rick Pollack said, “Patients should be confident in knowing that their hospital is their lifeline to access care in their community. The cuts proposed today raise serious concerns about how hospitals and health systems can ensure they serve as the safety net for their patients.”  For more on AHA's reaction, see the AHA Stat blog.
 
At today’s hearing, Azar announced that National Cancer Institute Director Norman Sharpless, M.D., will serve as acting Food and Drug Administration commissioner after current commissioner Scott Gottlieb, M.D., departs in about a month.

Headline
The Senate Finance Committee Sept. 24 held a markup where it advanced the nomination of Chris Klomp for deputy secretary of the Department of Health and Human…
Headline
The AHA commented Sept. 21 on the Centers for Medicare & Medicaid Services’ proposed rule to implement the changes to Medicaid provider tax policies that…
Headline
The Centers for Medicare & Medicaid Services Sept. 15 announced an expansion of its outcome-aligned payment model offering technology-supported care to…
Headline
The House Energy and Commerce Subcommittee on Health held a hearing Sept. 15 to discuss more than a dozen legislative proposals regarding Medicare provider…
Headline
The AHA Aug. 31 joined a coalition led by LeadingAge and other national healthcare organizations in submitting comments to the Centers for Medicare &…
Headline
The AHA Aug. 17 provided comments to the Centers for Medicare & Medicaid Services on its proposed rule to codify in regulation the Medicare Drug Price…